Brazilian Rare Earths (ASX: BRE) starts pilot plant as partners fund 59% of Stage II

Brazilian Rare Earths Limited (ASX: BRE; OTCQX: BRELY) has commissioned the Stage I metallurgical pilot plant at Camaçari in Brazil’s Bahia state and produced its first rare earth mineral concentrate, moving the company from laboratory-scale process development into bulk metallurgical testing that will feed directly into pre-feasibility engineering. The company has simultaneously secured R$6.4 million, approximately A$1.7 million, of partner funding for the Stage II hydrometallurgical pilot plant.

SENAI CIMATEC and partner organisation EMBRAPII are contributing approximately 59% of the expected Stage II capital and operating costs. That implies total Stage II spending of roughly A$2.9 million and leaves Brazilian Rare Earths responsible for approximately A$1.2 million on a simple proportional basis, although final expenditure can change as detailed design and construction progress. Equipment is expected on site during the fourth quarter of 2026, with Stage II commissioning planned for the second quarter of 2027.

The distinction between the two stages matters commercially. Stage I uses physical beneficiation to upgrade mineralised material into concentrate, while Stage II will introduce hydrometallurgical extraction and separation intended to produce neodymium-praseodymium oxide, heavy rare earth concentrate and uranium yellowcake. Product samples will then support customer qualification and potential offtake discussions while giving engineers operating data for the proposed Camaçari refinery.

Investors responded positively to the September 8 ASX announcement, which was released at 9:30 a.m. AEST. Brazilian Rare Earths shares closed at A$3.78, up 3.28% from A$3.66, after trading as high as A$3.99 on approximately 703,000 shares.

Why does producing the first rare earth concentrate matter more than simply completing construction?

Commissioning confirms that the full Stage I beneficiation circuit can operate as an integrated process rather than as a collection of individual laboratory tests. Brazilian Rare Earths can now run systematic campaigns using feedstocks from across its Rocha da Rocha mineral province, generating larger datasets around recoveries, concentrate grades, material behaviour and equipment performance.

Those results will influence the processing flowsheet being incorporated into the company’s pre-feasibility work. Changes that appear relatively minor at pilot scale, such as grind size, reagent requirements, mineral recovery or concentrate quality, can have substantial effects on the capital and operating costs of a future commercial operation.

The pilot plant also provides material for Stage II. Hydrometallurgical separation cannot be meaningfully optimised without representative concentrate from the upstream beneficiation circuit, so producing consistent Stage I material connects mine feed directly with the proposed refinery process.

That makes the milestone more useful than simply declaring that a building and equipment have been commissioned. Brazilian Rare Earths is beginning to generate the engineering evidence needed to test whether the integrated ore-to-oxide concept can work continuously at progressively larger scale.

How much does the 59% partner contribution really reduce Brazilian Rare Earths’ funding burden?

The R$6.4 million contribution is equivalent to approximately A$1.7 million and covers about 59% of expected Stage II capital and operating costs. On that basis, the total programme cost implied by the funding percentage is approximately A$2.9 million, leaving around A$1.2 million attributable to Brazilian Rare Earths before any changes to the programme budget.

That is financially modest relative to the company’s balance sheet. Brazilian Rare Earths ended June 2026 with approximately A$134.4 million of cash and cash equivalents after using A$28.1 million in operating activities during the half year.

The strategic benefit of co-funding therefore extends beyond preserving cash. SENAI CIMATEC provides technical infrastructure and local industrial capability, while Carester contributes rare earth separation expertise, allowing Brazilian Rare Earths to use specialist partners rather than build every technical capability internally.

Keeping the company’s own Stage II contribution near A$1 million also preserves capital for drilling, feasibility work and the much larger development programme that follows successful piloting. The pilot plant may be relatively inexpensive, but proving a commercial mining-and-refining platform will require orders of magnitude more capital.

Why is Stage II a bigger commercial test than the beneficiation plant?

Physical beneficiation determines whether Brazilian Rare Earths can economically concentrate valuable minerals before chemical processing. Stage II addresses the more difficult question of whether those concentrates can be chemically separated into saleable high-value products at acceptable recoveries, purity and cost.

The target product suite includes NdPr oxide and a heavy rare earth concentrate, both strategically important because permanent magnets used in electric vehicles, robotics, wind turbines and defence applications depend on rare earth materials. Brazilian Rare Earths also plans to test uranium yellowcake production as a co-product, although the company has cautioned that co-product economics remain dependent on recoveries, product quality, costs and commercial terms.

Producing material is also different from qualifying it with customers. Magnet and specialist-material buyers require consistent chemistry, purity and physical specifications before committing to long-term purchasing arrangements, so pilot samples can become an important bridge between geological resources and commercial discussions.

Stage II commissioning in Q2 2027 is therefore one of the most important technical catalysts in the current development schedule. Successful operation would not establish a commercial refinery by itself, but it would materially improve the quality of the evidence supporting the next engineering phase.

Why does Brazilian Rare Earths still face a much larger financing challenge beyond the pilot plants?

Brazilian Rare Earths is exceptionally well funded for an exploration and study-stage company, but commercial development sits on a completely different scale. Its June half-year balance sheet showed A$134.4 million of cash, while exploration and evaluation spending accelerated substantially as the company expanded drilling and technical studies.

The company’s integrated development concept involves mining, beneficiation, transport and downstream refining rather than a simple concentrate-export operation. Building that system would require major project financing, permitting, infrastructure and construction decisions after feasibility work is completed.

That explains why partner funding remains valuable despite Brazilian Rare Earths already having significant cash. Spending A$1 million less on a pilot programme is not transformational by itself, but maintaining capital discipline during technical de-risking reduces how quickly the company consumes shareholder funds before the much larger project-finance requirement arrives.

The investment case therefore needs to separate pilot success from commercial funding. Brazilian Rare Earths has now demonstrated Stage I concentrate production and secured most of the cost of Stage II from partners, but investors still need the pre-feasibility study, hydrometallurgical results, product qualification and a credible commercial financing pathway.

What does the 3.3% share-price gain say about expectations after BRE’s recent volatility?

Brazilian Rare Earths closed September 8 at A$3.78, up 3.28%, after touching A$3.99 during the session. The stock had already increased 4.57% on September 7, lifting it from A$3.50 at the September 4 close to A$3.78 over two sessions.

The move remains modest compared with the stock’s broader range. Brazilian Rare Earths has traded between approximately A$2.90 and A$7.07 over the past year, while the September close gives the company an equity market value of roughly A$1 billion.

That valuation means investors are already assigning substantial value to future commercial development despite the absence of operating rare earth revenue. Technical milestones therefore need to progressively justify the expectations embedded in the share price rather than merely demonstrate that exploration continues.

Stage I commissioning advances that process, but Stage II is the more revealing test. Brazilian Rare Earths has produced concentrate; the next step is demonstrating that it can transform representative bulk material into consistent separated products that customers may eventually be prepared to buy.